Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Adenocarcinoma, Clear Cell × rucaparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Fallopian Tube Neoplasms 5 Ovarian Neoplasms 4 Carcinoma, Ovarian Epithelial 3 Neoplasms 2 Recurrence 1 Prostatic Neoplasms 1 Pathologic Complete Response 1 Metastatic Castration Resistant Prostate Cancer 1 Genital Neoplasms, Male 1 Adenocarcinoma, Clear Cell 1

Interventions

rucaparib 1 Taxes 1 Paclitaxel 1 Immunoglobulin G 1 Gemcitabine 1 Docetaxel 1 Disulfides 1 Carboplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04227522 2024-11-15

MAMOC

North Eastern German Society of Gynaecological Oncology

Phase 3 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms, Adenocarcinoma, Clear Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡